Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Advanced glycation end products (AGEs) are long-lived tissue proteins that accumulate in diabetes. Skin AGEs measured in biopsy specimens strongly correlated with complications of diabetes. AGEs can also be measured noninvasively by the AGE Reader™ (DiagnOptics B.V., Groningen, The Netherlands). The aim of this review was to systematically review all articles on the association between skin autofluorescence (SAF), measured by the AGE Reader, and complications of diabetes. METHODS: We screened PubMed for studies on SAF and complications in diabetes mellitus type 1 and type 2. Seven articles met the inclusion criteria. RESULTS: All studies showed positive associations of SAF with one or more complications (all-cause mortality, cardiovascular mortality, micro- and macrovascular complications, neuropathy, and nephropathy), except retinopathy. Only three studies were of prospective design, with a follow-up of 3-5 years; the other four studies were cross-sectional. Studies were of large clinical heterogeneity. CONCLUSIONS: This systematic review of literature showed an association of SAF with end-organ complications in diabetes, except retinopathy, in all seven studies. However, studies were of large clinical heterogeneity, only three studies had a prospective design, and five studies were from the same research group. More prospective studies, with a longer period of follow-up, larger group size, and strict definitions of complications and end points, are needed to demonstrate the potential role and benefit in clinical management before the widespread use of the AGE Reader can be recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597 · cited 1×
“First, AGEs can form cross-links with proteins that affect the threedimensional structure and thereby the functions of these proteins.(6) Second, AGEs can cause harmful effects by the activation of receptors for AGEs.”
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Cited by
Advanced glycation end products: Key players in skin aging?
Gkogkolou, P., & Böhm, M. (2012) · Dermato-Endocrinology · doi:10.4161/derm.22028 · Cited by 584
Fishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330
Phenomic studies on diseases: potential and challenges
Ying, W. (2023) · Phenomics · doi:10.1007/s43657-022-00089-4 · Cited by 96
“Second, there have been studies indicating that the autofluorescence (AF) of the skin and the eyes can become diagnostic biomarkers for diabetes (Sparrow et al. 1992), which originates from the advanced glycation products (AGEs) of collagen (Bos et al. 2011; Mulder et al. 2006).”
BackgroundSelf-tracking of Physical Activity in People With Type 2 Diabetes: A Randomized Controlled Trial
Kooiman, T. J. M., de Groot, M., Hoogenberg, K., Krijnen, W. P., van der Schans, C. P., & Kooy, A. (2018) · CIN: Computers, Informatics, Nursing · doi:10.1097/cin.0000000000000443 · Cited by 78
Metadata
- Authors
- Bos, D. C., de Ranitz-Greven, W. L., & de Valk, H. W.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2011-07
- Volume
- 13
- Issue
- 7
- Pages
- 773-779
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2081901990
- Cited by
- 93
- References
- 3
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review. https://app.cochat.ai/papers/10.1089/dia.2011.0034
- The paper
- Bos, D. C., de Ranitz-Greven, W. L., & de Valk, H. W. (2011). Advanced Glycation End Products, Measured as Skin Autofluorescence and Diabetes Complications: A Systematic Review. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2011.0034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.